Css LLC Ocular Therapeutix, Inc Call Options Transaction History

Css LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $50,634 - $85,554	-19,400 Reduced 13.85%	120,700 $339,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $491,209 - $780,650	120,100 Added 600.5%	140,100 $581,000
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $62,832 - $123,114	10,200 Added 104.08%	20,000 $139,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $95,060 - $140,532	9,800 New	9,800 $98,000
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $177,276 - $252,912	-13,200 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $18,984 - $26,532	1,200 Added 10.0%	13,200 $217,000
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $128,933 - $374,085	-16,300 Reduced 57.6%	12,000 $248,000
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $288,512 - $386,903	-39,200 Reduced 58.07%	28,300 $215,000
Q2 2020 Aug 14, 2020	SELL	$4.67 - $8.95 $100,405 - $192,424	-21,500 Reduced 24.16%	67,500 $563,000
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $351,550 - $658,600	89,000 New	89,000 $441,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.